Hematologic Malignancies
Showing 101 - 125 of 136
Compare Two Types of Transplant in Adult Hematologic
Unknown status
- Hematologic Malignancies
- transplantation
- (no location specified)
Mar 5, 2015
Hematologic Malignancies, Solid Tumors Trial in Amsterdam (omacetaxine mepesuccinate)
Completed
- Hematologic Malignancies
- Solid Tumors
- omacetaxine mepesuccinate
-
Amsterdam, NetherlandsTeva Investigational Site 38045
Jan 29, 2015
Hematologic Malignancies Trial in Seoul (ramosetron)
Unknown status
- Hematologic Malignancies
-
Seoul, Korea, Republic ofCatholic Blood & Marrow Transplantation Center, Seoul St Mary's
Dec 5, 2014
Depletion of Haplotype Mismatched Alloreactive T Cells
Withdrawn
- Hematologic Malignancies
- Hematopoietic Stem Cell Transplantation
- collection of peripheral blood and apheresis samples
- (no location specified)
Sep 18, 2014
Hematologic Malignancies Trial in Indianapolis (clofarabine)
Completed
- Hematologic Malignancies
-
Indianapolis, IndianaIndiana University Cancer Center
Sep 17, 2014
GVHD, Hematologic Malignancies Trial (drug, other, procedure)
Completed
- Graft Versus Host Disease
- Hematologic Malignancies
- Palifermin
- +4 more
- (no location specified)
Sep 12, 2014
Hematologic Diseases, Hematologic Malignancies Trial in Atlanta (Granulocyte Colony Stimulating Factor)
Completed
- Hematologic Diseases
- Hematologic Malignancies
- Granulocyte Colony Stimulating Factor
-
Atlanta, GeorgiaChildren's Healthcare of Atlanta/Emory University
Aug 19, 2014
Hematologic Malignancies Trial in Tampa (Pentostatin, Busulfan, Rituximab)
Completed
- Hematologic Malignancies
- Pentostatin
- +3 more
-
Tampa, FloridaH. Lee Moffitt Cancer Center & Research Institute
May 30, 2014
Hematologic Malignancies, GVHD Trial in Ann Arbor, St. Louis (reduced intensity, related donor stem cell transplant, tacrolimus
Completed
- Hematologic Malignancies
- Graft vs Host Disease
- reduced intensity, related donor stem cell transplant
- +3 more
-
Ann Arbor, Michigan
- +1 more
Mar 5, 2014
Cord Blood Stem Cell Transplantation, Hematologic Malignancies Trial in United States (Cord blood transplantation)
Completed
- Cord Blood Stem Cell Transplantation
- Hematologic Malignancies
- Cord blood transplantation
-
Duarte, California
- +9 more
Mar 7, 2014
Hematologic Malignancies Trial in Charlottesville (drug, radiation, biological)
Terminated
- Hematologic Malignancies
- Fludarabine
- +4 more
-
Charlottesville, VirginiaUniversity of Virginia
Feb 10, 2014
Hematologic Malignancies Trial in Duluth, Durham (CAMPATH (alemtuzumab))
Terminated
- Hematologic Malignancies
- CAMPATH (alemtuzumab)
-
Duluth, Minnesota
- +1 more
Feb 4, 2014
Hematologic Malignancies, Allogeneic Stem Cell Transplantation Trial in Boston (Fludarabine, Melphalan, Antithymocyte Globulin)
Completed
- Hematologic Malignancies
- Allogeneic Stem Cell Transplantation
- Fludarabine
- +4 more
-
Boston, Massachusetts
- +1 more
Oct 7, 2013
Hematologic Malignancies Trial in Boston (Bortezomib (Velcade), Tacrolimus, Methotrexate)
Completed
- Hematologic Malignancies
- Bortezomib (Velcade)
- +3 more
-
Boston, Massachusetts
- +1 more
Jun 19, 2013
Hematologic Diseases, Hematologic Malignancies Trial in Montreal (Donor lymphocyte preparation depleted of functional host
Completed
- Hematologic Diseases
- Hematologic Malignancies
- Donor lymphocyte preparation depleted of functional host alloreactive T-cells (ATIR)
-
Montreal, Quebec, CanadaMaisonneuve-Rosemont Hospital
Jun 19, 2013
Hematologic Malignancies Trial in Durham (Non-neutropenic Diet)
Completed
- Hematologic Malignancies
- Non-neutropenic Diet
-
Durham, North CarolinaDuke University Medical Center
May 8, 2013
Hematologic Malignancies Trial in Houston (Cloretazine, Fludarabine)
Completed
- Hematologic Malignancies
-
Houston, TexasUT MD Anderson Cancer Center
Jul 27, 2012
Transplantation Using Umbilical Cord Blood and Human
Unknown status
- Hematologic Malignancies
- UCB and HPDSC
-
New Orleans, LouisianaLouisiana State University Children's Hospital
Apr 9, 2012
Hematologic Malignancies Trial in Atlanta (Busulfan, Cyclophosphamide and Fludarabine)
Completed
- Hematologic Malignancies
- Busulfan, Cyclophosphamide and Fludarabine
-
Atlanta, GeorgiaEmory Universtiy Winship Cancer Institute
Apr 5, 2012
Hematologic Malignancies Trial in Australia, Canada, Korea, Republic of (GSK21110183)
Completed
- Hematologic Malignancies
-
Sydney, New South Wales, Australia
- +3 more
Apr 3, 2012